Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA-Directed DNA Polymerase | 11 | 2015 | 35 | 2.600 |
Why?
|
| DNA, Mitochondrial | 10 | 2017 | 84 | 2.350 |
Why?
|
| Mitochondrial Diseases | 6 | 2015 | 24 | 1.660 |
Why?
|
| Zebrafish | 8 | 2015 | 187 | 1.580 |
Why?
|
| Mitochondria | 8 | 2017 | 643 | 1.450 |
Why?
|
| Mutation | 10 | 2015 | 1213 | 1.000 |
Why?
|
| Zebrafish Proteins | 3 | 2015 | 100 | 0.950 |
Why?
|
| Energy Metabolism | 4 | 2015 | 222 | 0.930 |
Why?
|
| DNA Damage | 2 | 2017 | 190 | 0.820 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 5 | 2009 | 15 | 0.780 |
Why?
|
| DNA Polymerase gamma | 11 | 2015 | 12 | 0.670 |
Why?
|
| Genomic Instability | 1 | 2017 | 41 | 0.580 |
Why?
|
| Environmental Pollutants | 1 | 2017 | 180 | 0.510 |
Why?
|
| Embryonic Development | 1 | 2015 | 100 | 0.480 |
Why?
|
| Vitamin K 3 | 1 | 2013 | 3 | 0.470 |
Why?
|
| Codon, Nonsense | 3 | 2009 | 15 | 0.430 |
Why?
|
| Adenosine Triphosphate | 4 | 2015 | 314 | 0.430 |
Why?
|
| Embryo, Nonmammalian | 2 | 2015 | 64 | 0.430 |
Why?
|
| Anticonvulsants | 1 | 2013 | 223 | 0.400 |
Why?
|
| Microarray Analysis | 1 | 2011 | 63 | 0.390 |
Why?
|
| Epilepsy | 1 | 2013 | 336 | 0.340 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 301 | 0.330 |
Why?
|
| Mutant Proteins | 1 | 2009 | 45 | 0.330 |
Why?
|
| Catalytic Domain | 2 | 2006 | 99 | 0.320 |
Why?
|
| Mitochondria, Heart | 2 | 2007 | 53 | 0.300 |
Why?
|
| Animals | 13 | 2017 | 20880 | 0.300 |
Why?
|
| Lamivudine | 1 | 2007 | 24 | 0.290 |
Why?
|
| Zidovudine | 1 | 2007 | 27 | 0.290 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2007 | 28 | 0.290 |
Why?
|
| Oxygen Consumption | 3 | 2015 | 258 | 0.260 |
Why?
|
| Anti-HIV Agents | 1 | 2007 | 135 | 0.260 |
Why?
|
| Alternative Splicing | 1 | 2005 | 93 | 0.250 |
Why?
|
| Alleles | 1 | 2005 | 386 | 0.240 |
Why?
|
| Mitochondrial Proteins | 2 | 2015 | 113 | 0.240 |
Why?
|
| Amino Acid Substitution | 3 | 2008 | 137 | 0.210 |
Why?
|
| Molecular Sequence Data | 4 | 2009 | 1446 | 0.200 |
Why?
|
| Chondroitin Sulfates | 1 | 2001 | 44 | 0.200 |
Why?
|
| Osteoarthritis | 1 | 2001 | 73 | 0.190 |
Why?
|
| Protein Subunits | 3 | 2009 | 99 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2001 | 155 | 0.180 |
Why?
|
| Cell Line | 4 | 2015 | 1752 | 0.170 |
Why?
|
| Enzyme Stability | 2 | 2009 | 30 | 0.150 |
Why?
|
| Ecotoxicology | 1 | 2017 | 4 | 0.150 |
Why?
|
| Gene-Environment Interaction | 1 | 2017 | 31 | 0.150 |
Why?
|
| Point Mutation | 2 | 2009 | 97 | 0.150 |
Why?
|
| Morpholinos | 2 | 2015 | 8 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 204 | 0.140 |
Why?
|
| Myocardium | 3 | 2015 | 1204 | 0.140 |
Why?
|
| Protein Conformation | 2 | 2008 | 362 | 0.140 |
Why?
|
| Humans | 14 | 2017 | 68549 | 0.140 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 1082 | 0.130 |
Why?
|
| Animal Fins | 1 | 2015 | 3 | 0.130 |
Why?
|
| Metalloproteases | 1 | 2015 | 9 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2015 | 41 | 0.130 |
Why?
|
| Models, Molecular | 2 | 2008 | 546 | 0.130 |
Why?
|
| Glycolysis | 1 | 2015 | 79 | 0.130 |
Why?
|
| Fishes | 1 | 2015 | 77 | 0.130 |
Why?
|
| 2,4-Dinitrophenol | 1 | 2015 | 6 | 0.130 |
Why?
|
| Oxidative Phosphorylation | 1 | 2015 | 54 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2017 | 269 | 0.130 |
Why?
|
| Regeneration | 1 | 2015 | 105 | 0.120 |
Why?
|
| Models, Animal | 1 | 2015 | 252 | 0.120 |
Why?
|
| Motor Neurons | 1 | 2015 | 98 | 0.120 |
Why?
|
| Electron Transport Complex IV | 1 | 2014 | 33 | 0.120 |
Why?
|
| Pentylenetetrazole | 1 | 2013 | 10 | 0.120 |
Why?
|
| Naphthoquinones | 1 | 2013 | 14 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2015 | 714 | 0.120 |
Why?
|
| Swimming | 1 | 2013 | 38 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 114 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 328 | 0.110 |
Why?
|
| Drug Interactions | 1 | 2013 | 289 | 0.110 |
Why?
|
| Retina | 1 | 2015 | 252 | 0.110 |
Why?
|
| Copper | 1 | 2014 | 149 | 0.110 |
Why?
|
| Circular Dichroism | 2 | 2009 | 99 | 0.100 |
Why?
|
| Mice | 4 | 2015 | 8474 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 2077 | 0.100 |
Why?
|
| Cell Respiration | 1 | 2011 | 47 | 0.100 |
Why?
|
| Protons | 1 | 2011 | 57 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2011 | 121 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2017 | 2004 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 954 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 659 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 742 | 0.090 |
Why?
|
| Base Sequence | 2 | 2009 | 1015 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 618 | 0.090 |
Why?
|
| Linear Models | 1 | 2011 | 521 | 0.090 |
Why?
|
| Spodoptera | 2 | 2009 | 21 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.090 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 24 | 0.090 |
Why?
|
| RNA Splicing | 1 | 2009 | 32 | 0.090 |
Why?
|
| Exonucleases | 1 | 2009 | 5 | 0.080 |
Why?
|
| Haplotypes | 1 | 2009 | 174 | 0.080 |
Why?
|
| RNA Stability | 1 | 2009 | 55 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 60 | 0.080 |
Why?
|
| Trinucleotide Repeats | 1 | 2008 | 8 | 0.080 |
Why?
|
| Base Pairing | 1 | 2008 | 15 | 0.080 |
Why?
|
| Exons | 2 | 2006 | 122 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2008 | 67 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 132 | 0.080 |
Why?
|
| DNA Replication | 1 | 2009 | 167 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2008 | 220 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2007 | 57 | 0.070 |
Why?
|
| DNA | 2 | 2006 | 597 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 181 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2007 | 73 | 0.070 |
Why?
|
| Nucleotides | 1 | 2006 | 29 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 562 | 0.070 |
Why?
|
| Tryptophan | 1 | 2006 | 65 | 0.070 |
Why?
|
| Serine | 1 | 2006 | 99 | 0.070 |
Why?
|
| Glycine | 1 | 2006 | 89 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2007 | 304 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2550 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2007 | 396 | 0.070 |
Why?
|
| Codon, Terminator | 1 | 2005 | 6 | 0.070 |
Why?
|
| Cycloheximide | 1 | 2005 | 50 | 0.070 |
Why?
|
| Thermolysin | 1 | 2005 | 3 | 0.070 |
Why?
|
| Ethylmaleimide | 1 | 2005 | 9 | 0.070 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2005 | 12 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 627 | 0.070 |
Why?
|
| Androstadienes | 1 | 2005 | 41 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2005 | 31 | 0.070 |
Why?
|
| Threonine | 1 | 2005 | 47 | 0.060 |
Why?
|
| Alanine | 1 | 2005 | 38 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 251 | 0.060 |
Why?
|
| Caffeine | 1 | 2005 | 81 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 208 | 0.060 |
Why?
|
| Brain | 1 | 2015 | 2176 | 0.060 |
Why?
|
| Hot Temperature | 1 | 2005 | 152 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 167 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2015 | 123 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2006 | 332 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2015 | 172 | 0.060 |
Why?
|
| Infant | 1 | 2009 | 2891 | 0.050 |
Why?
|
| Synovial Fluid | 1 | 2001 | 16 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2006 | 718 | 0.050 |
Why?
|
| Joints | 1 | 2001 | 30 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1663 | 0.050 |
Why?
|
| Male | 4 | 2009 | 37283 | 0.050 |
Why?
|
| Pregnancy | 1 | 2007 | 2334 | 0.050 |
Why?
|
| Epitopes | 1 | 2001 | 146 | 0.050 |
Why?
|
| Range of Motion, Articular | 1 | 2001 | 139 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 507 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 511 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2005 | 3187 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 1753 | 0.040 |
Why?
|
| Fractals | 1 | 2015 | 5 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 39 | 0.030 |
Why?
|
| Body Size | 1 | 2015 | 39 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 89 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 167 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 48 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 266 | 0.030 |
Why?
|
| Female | 3 | 2007 | 38021 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 434 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 946 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 47 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 451 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2009 | 34 | 0.020 |
Why?
|
| Catalysis | 1 | 2009 | 123 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 230 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 254 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 631 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 1047 | 0.020 |
Why?
|
| Adult | 2 | 2006 | 21379 | 0.020 |
Why?
|
| Deoxyguanosine | 1 | 2006 | 4 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 1027 | 0.020 |
Why?
|
| Pedigree | 1 | 2006 | 159 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 302 | 0.020 |
Why?
|
| Aged | 1 | 2001 | 14842 | 0.020 |
Why?
|
| Brain Diseases | 1 | 2006 | 78 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 492 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2006 | 193 | 0.010 |
Why?
|
| Middle Aged | 1 | 2001 | 21119 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1033 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2006 | 738 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 2222 | 0.010 |
Why?
|
| Child | 1 | 2006 | 6401 | 0.010 |
Why?
|